Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma

  • Rose P
  • Nerenstone S
  • Brady M
  • et al.
358Citations
Citations of this article
125Readers
Mendeley users who have this article in their library.

Abstract

We evaluated the effect of adding secondary cytoreductive surgery to postoperative chemotherapy on progression-free survival and overall survival among patients who had advanced ovarian cancer and residual tumor exceeding 1 cm in diameter after primary surgery.

Cite

CITATION STYLE

APA

Rose, P. G., Nerenstone, S., Brady, M. F., Clarke-Pearson, D., Olt, G., Rubin, S. C., … Small, J. M. (2004). Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma. New England Journal of Medicine, 351(24), 2489–2497. https://doi.org/10.1056/nejmoa041125

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free